Regeneron Pharmaceuticals (REGN) Other Gross PP&E Adjustments (2016 - 2024)
Historic Other Gross PP&E Adjustments for Regeneron Pharmaceuticals (REGN) over the last 16 years, with Q4 2025 value amounting to $7.2 billion.
- Regeneron Pharmaceuticals' Other Gross PP&E Adjustments rose 1370.21% to $7.2 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $7.2 billion, marking a year-over-year increase of 1370.21%. This contributed to the annual value of $7.2 billion for FY2025, which is 1370.21% up from last year.
- Per Regeneron Pharmaceuticals' latest filing, its Other Gross PP&E Adjustments stood at $7.2 billion for Q4 2025, which was up 1370.21% from $6.3 billion recorded in Q4 2024.
- Over the past 5 years, Regeneron Pharmaceuticals' Other Gross PP&E Adjustments peaked at $7.2 billion during Q4 2025, and registered a low of -$15.6 million during Q3 2022.
- For the 5-year period, Regeneron Pharmaceuticals' Other Gross PP&E Adjustments averaged around $4.7 billion, with its median value being $5.2 billion (2022).
- As far as peak fluctuations go, Regeneron Pharmaceuticals' Other Gross PP&E Adjustments skyrocketed by 1324.78% in 2022, and later surged by 1470.52% in 2023.
- Quarter analysis of 5 years shows Regeneron Pharmaceuticals' Other Gross PP&E Adjustments stood at $4.2 billion in 2021, then rose by 13.25% to $4.8 billion in 2022, then increased by 14.71% to $5.5 billion in 2023, then rose by 14.06% to $6.3 billion in 2024, then grew by 13.7% to $7.2 billion in 2025.
- Its Other Gross PP&E Adjustments stands at $7.2 billion for Q4 2025, versus $6.3 billion for Q4 2024 and $5.5 billion for Q4 2023.